Medherant
Phase 1Medherant is developing innovative transdermal therapies using its proprietary TEPI Patch® technology for safe and convenient drug delivery.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $1.2M
About
Medherant is developing innovative transdermal therapies using its proprietary TEPI Patch® technology for safe and convenient drug delivery.
Drug Delivery
Funding History
1Total raised:$1.2M
Grant$1.2MMay 15, 2021